Caxton Corp
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$4.0M
Q ending 2026-03-31
Prior quarter
$4.3M
Q ending 2025-12-31
Change
-6.0% QoQ · -20.8% YoY
Positions
7
reported holdings
Largest positions
All 7 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Spdr Gold Tr | GLD | Shares | $3.3M | 8K |
| Berkshire Hathaway Inc Del | BRK/B | Shares | $348K | 727 |
| Kyverna Therapeutics Inc | KYTX | Shares | $162K | 19K |
| Lexeo Therapeutics Inc | LXEO | Shares | $80K | 14K |
| X4 Pharmaceuticals Inc | XFOR | Shares | $64K | 16K |
| Inhibikase Therapeutics Inc | IKT | Shares | $48K | 28K |
| Alx Oncology Hldgs Inc | ALXO | Shares | $42K | 21K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.